卷 94, 编号 5 (2022) |
Original articles |
Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugs |
(Rus)
|